A PILOT CLINICAL TRIAL OF OROTECAN (VAL-413), A NOVEL ORAL DOSAGE FORMULATION OF IRINOTECAN: IMPLICATIONS FOR PEDIATRIC BRAIN TUMORS

Conference Paper

Full Text

Link to Item

Duke Authors

Wagner, Lars Martin

Cited Authors

Brown, D; Bacha, J; Wagner, L; Leggas, M; Kanekal, S; Lopez, L; Sankar, N

Published Date

November 2020

Published In

Neuro Oncology

Volume / Issue

22 /

Start / End Page

60 - 60

Electronic International Standard Serial Number (EISSN)

1523-5866

International Standard Serial Number (ISSN)

1522-8517